NCT00005938View on ClinicalTrials.gov

DX-8951f in Treating Patients With Biliary Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2000

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Interventions
DRUG

exatecan mesylate

Trial Locations (5)

10021

Memorial Sloan-Kettering Cancer Center, New York

78229

Cancer Therapy & Research Center, San Antonio

80262

University of Colorado Cancer Center, Denver

75235-9154

Simmons Cancer Center - Dallas, Dallas

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY